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Abstract
Psychological distress is common among patients with chronic obstructive pulmonary disease (COPD). This
study aimed to assess whether a 10-minute mindfulness intervention reduces distress and breathlessness,
improves mood and increases mindfulness among hospital inpatients following acute exacerbation of
COPD.Fifty patients were recruited following an acute admission. The immediate effects of a 10-minute
mindfulness-based body scan were compared with a control intervention. Participants were randomized to
receive either a mindfulness-based body scan (n ¼ 24) or a control condition (n ¼ 26) via a 10-minute audio
recording. Participants completed a self-assessment survey, including the Borg scale for breathlessness,
Philadelphia Mindfulness Scale and Hospital Anxiety and Depression Scale. They then completed six brief
single item measures of dyspnoea, anxiety, depression, happiness, stress and mindfulness before and after
the intervention daily for three consecutive days. Acceptability was rated according to ‘usefulness’ and whether
they would recommend the intervention to other patients. Results showed that there was a tendency for
change in most outcomes, but no significant differences between the groups. Most participants rated the
intervention as useful and would recommend it. Existing knowledge of mindfulness interventions among
these patients is very limited and this study may be helpful in the development of other brief interventions.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a
chronic inflammatory lung condition characterized by
progressive dyspnoea (breathlessness) on exertion,
which eventually has a significant impact on physical
functioning and quality of life.1 It presents with fati-
gue, persistent cough and increased sputum produc-
tion and includes a combination of emphysema and
chronic bronchitis.2 In most cases, specific medical
therapy cannot reverse the underlying condition and
so the main aims of treatment are to ameliorate the
symptoms, prevent exacerbations and reduce the
impact of the disease.
Mood disorders are common among COPD patients.
The prevalence of depression ranges from 10% to 42%
and anxiety between 9% and 58%.3,4 This increases
with the severity of the condition and may impact on
the experience of dyspnoea. Patients with depressive
symptoms are more likely to suffer exacerbations, fre-
quent readmissions and worse survival.5–7 Anxiety has
been linked to greater disability in patients with COPD,
an increased frequency of hospital admissions for acute
exacerbations and dyspnoea.8–10 Pharmacological
interventions for managing anxiety and depression in
COPD patients may be helpful but frequent adverse
effects often limit their use.11 COPD predominantly
affects middle-aged and older patients who may also
experience other co-morbidities and who may be more
at risk of drug interactions. Therefore, there is a need to
develop and assess non-pharmacological interventions
in patients with COPD.
Psychological interventions such as mindfulness
techniques may be appropriate for managing symp-
toms of anxiety, depression and dyspnoea among those
with COPD. Mindfulness is defined as ‘the awareness
that emerges through paying attention to purpose, in
the present moment, and non-judgementally to the
unfolding of experience moment-to-moment’.12 A pro-
gramme of mindfulness-based stress reduction
(MBSR) has been shown to reduce stress, anxiety and
depression in a range of clinical and non-clinical
conditions.13–15 Most MBSR programmes are inten-
sive, typically entailing an 8-week group intervention
delivered by a specialist.16 There is a limited literature
examining the use of mindfulness among COPD
patients and no studies examining the use of brief inter-
ventions of 30 minutes or less. Other interventions that
have focused on breathing, meditation and exercise
such as yoga often follow a training period of several
weeks and have also had limited success.17 Holland
et al.18 conducted a Cochrane review of breathing exer-
cises delivered over several weeks for COPD patients
and reported that although functional capacity
improved, effects on dyspnoea and quality of life were
inconsistent. Other studies have found little effect on
function but significant improvements in quality of
life.19 One randomized controlled trial of a
mindfulness-based therapy for dyspnoea in 84 COPD
patients, participating in an 8-week programme of
weekly group meetings and daily self-administered
practice, showed no significant improvements in dys-
pnoea, health-related quality of life, stress or mindful-
ness in the intervention group. However, retention rates
were low in many patients withdrawing before even the
first session due to transport difficulties, competing
time commitments and other disease-related issues.20
Brief and self-management-type mindfulness pro-
grammes, which can be used in the individual’s own
environment and with little training or no, may bemore
appropriate for those with COPD who are likely to
have reduced mobility and higher levels of fatigue.
Increasing the hours spent attending a mindfulness pro-
gramme does not tend to reduce reports of distress,16
but the amount of ‘home-based’ practice of mindful-
ness is associated with greater well-being.16,21–23
Moreover, many patients will not need or be inter-
ested in attending highly intensive programmes.
Mindfulness-based body scans may be appropriate
self-management interventions. Previous studies
have shown that patients report beneficial effects
of brief mindfulness interventions, such as greater
relaxation and improved coping.21 A very brief inter-
vention may be more appropriate and manageable for
some patients following an exacerbation of COPD
than the conventional mindfulness programme.
Body scans are a key component of mindfulness
meditation; they involve being directed to focus atten-
tion on the present moment through observing the
breath, and bodily sensations, and becoming aware,
and accepting without judgement, of any thoughts and
feelings which arise. The focus is not on controlling
body sensations or breathing but rather on accepting
and allowing these sensations to be as they are. MBSR
routinely employs a brief body scan, lasting anything
from 5 to 30 minutes.24 In other areas where discomfort
and difficult feelings need to be managed, brief body
scans have been shown to have an immediate benefi-
cial effect without the individuals having undergone an
MBSR programme. For example, a 10-minute body
scan reduced cigarette cravings and mood-related with-
drawal symptoms in abstinent smokers and reduced
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distress among those with chronic pain.25–27 To our
knowledge, no study has investigated the impact of a
very brief body scan on acute patients with COPD.
This study aimed to assess feasibility of conducting
a larger trial investigating the immediate and short-
term effects of a 10-minute mindfulness body scan in
reducing dyspnoea, anxiety and depression among
hospital in-patients admitted with an acute exacerba-
tion of COPD. This could be a useful opportunity to
provide patients with an additional intervention to
manage their symptoms during a short, acute hospital
admission. It was intended to assess whether patients
would be willing to participate in the in-hospital study
immediately following an acute admission, whether
the intervention was effective in improving mood and
dyspnoea and how acceptable patients found this
intervention.
Methods
Participants
Potential participants included all patients admitted to
an acute admissions ward in a London teaching hospital
with an acute exacerbation of COPD over a 10-month
period ending in September 2013. All patients were
screened by a respiratory physician and had a diagnosis
of COPD recorded in their medical notes. Forced
expiratory volume in the first second, a measure of lung
capacity, was not available for all participants at the
time of admission and was not therefore an essential
part of the inclusion criteria. Participants were excluded
if theywere unable to understandEnglish, aged less than
40 years (to avoid overlap in diagnoses with late onset
asthma), had respiratory failure or were too unwell to
participate, had signs of confusion or dementia (abbre-
viated mental state score < 8/10 and/or mini-mental
status examination score < 25/30), or diagnosis of a
pre-existing psychiatric disorder. Patients were
recruited as soon as their conditionwas stable following
admission to the acute ward. All eligible patients were
given information regarding the study and provided
informed written consent. The study was approved by
the local Research Ethics Committee (NRES Commit-
tee London-Surrey Borders 12/LO/1430).
Design and interventions
An experimental randomized controlled feasibility
study was conducted with a view to conducting a
larger study if the intervention was effective and
enough patients were willing to participate.
Participants were randomized by a computer-
generated list of random numbers using block rando-
mization to one of two groups: the experimental or
control group. The outcomes were not blinded. The
experimental group listened to a 10-minute audio
recording of a mindfulness-based body scan, adapted
from a previous study,28 which guided the patient to
focus on specific bodily and breathing sensations,
encouraging non-judgemental acceptance of thoughts
and feelings experienced in the moment.28 Patient’s
attention was guided to specific body parts in turn and
they were directed to acknowledge all sensations with-
out attempting to change them. The control group lis-
tened to a 10-minute audio recording of a natural history
text which had previously been used by another study as
an active control condition comparison with a body
scan.28,29 It is difficult to find an active control compa-
rable to the mindfulness-based body scan. We used an
oral reading of a natural history script because it seemed
more similar to the intervention and more appropriate
than music or nature sounds which are very subjective
and may hold different meanings for individuals.
There were no studies testing the immediate effects
of a brief mindfulness intervention among COPD
patients. It was therefore not possible to perform a
power calculation. Two similar studies showing ben-
efits for a body scan among smokers among patients
with chronic pain, however, allocated 15–30 patients
to each group.25,26,28 The present study, therefore,
adopted a conservative approach aiming to recruit
40 patients to each group. Based on a similar study,
it was assumed that at least 10% of patients would not
complete all stages of the study.28 Participants were
told the aim of the study was to find out whether there
was any improvement in dyspnoea and mood after
listening to the 10-minute audio guide.
Procedure
Both groups were asked to listen to the audio record-
ing in the acute ward at time 1 using earphones on an
MP3 player. Immediately before and after the record-
ing, participants completed a brief questionnaire (see
below). They were then asked to listen to their record-
ing again at least once, but as many times as they
liked, on each of the next 2 days and to complete the
questionnaire again on each occasion immediately
before and after, as at time 1, on both days. Partici-
pants were also asked how frequently they listened to
the recordings, and how they felt afterwards.
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Questionnaires were then either collected by the
research team or returned by mail if the participant
had been discharged home. Participants were com-
pensated with a £15 shopping voucher. The interven-
tion lasted 3 days in duration; however, some patients
may have been discharged by day 3 and therefore
completed the questionnaires at home.
Measures
Demographic details, including age, marital status,
ethnic group, diagnosis, smoking status and current
medication (including use of nicotine replacement
therapy), were collected at baseline. The Borg scale
is a non-linear scale used to allow patients to rate how
breathless they felt (no breathlessness at all ¼ 0 to
very, very severe breathlessness ¼ 10).4,30 The
20-item Philadelphia Mindfulness Scale (PHLMS)
was administered to assess trait-like qualities of
acceptance (10 items) and awareness (10 items) man-
ifest in daily life.31 The PHLMS asks respondents to
indicate how often they have had mindful experiences
in the past week; for example, ‘I am aware of what
thoughts are passing through my mind’ (1 ¼ never,
2 ¼ rarely, 3 ¼ sometimes, 4 ¼ often and 5 ¼ very
often). The Hospital Anxiety and Depression Scale
(HADS) was used to characterize the level of dis-
tress.32 The HADS is a widely used screening mea-
sure for anxiety and depression consisting of 14 items,
7 for anxiety and 7 for depression. Participants com-
pleted these measures on commencing the study and
again on completion.
Brief measures completed immediately before
and after the interventions
Immediately before and after listening to the record-
ings, participants completed ratings for six brief,
single-item measures. First, they were asked to rate
how breathless they felt (using the Borg dyspnoea 0 to
10 scale).10 They were then asked how anxious,
depressed, stressed and happy they felt at that moment
(rated as 1 ¼ not at all to 7 ¼ extremely). These items
were based on items from the HADS and the Mood
and Physical Symptoms scale.33 Mindfulness was
assessed using the first item from the PHLMS: ‘I
am aware of what thoughts are passing through my
mind’, (never ¼ 1 to very often ¼ 5). Brief measures
were used in order to reduce the questionnaire burden
on participants who were in-hospital patients under-
going continuing treatment.
On completion of the study, participants were
asked two additional questions used to assess the per-
ceived credibility of the questionnaire: ‘How useful
did you find listening to the audio-recording for help-
ing you relax?’ (1 ¼ not at all, 2 ¼ slightly useful,
3 ¼ moderately useful, 4 ¼ very useful and 5 ¼
extremely useful); and ‘Would you recommend this
strategy to others who are trying to manage their
illness?’ (1 ¼ definitely would not recommend,
2 ¼ probably would not recommend, 3 ¼ not sure,
4 ¼ probably would recommend and 5 ¼ definitely
would recommend).
Statistical analysis
First, we checked whether those who provided a com-
plete set of data, for all 3 days, had similar character-
istics to those for the total sample, particularly
regarding baseline pre-intervention scores for the
HADS, PHLMS, Borg dyspnoea scale and the number
of patients in the two study groups. Then, we exam-
ined whether the baseline characteristics of the inter-
vention and control groups were similar in the
subsample providing complete data.
Descriptive statistics for all baseline measures,
including pre-intervention scores for the HADS,
PHLMS and BORG dyspnoea scale, were produced
for the two groups. For the main analysis, the effect
of the body scan versus the control on ratings for the
measures administered immediately before and after
the interventions was assessed on days 1, 2 and 3. The
distributions of scores for all the measures were
skewed, and neither logarithmic nor square root trans-
formations produce normality; therefore, analysis of
covariance was not appropriate, nor was it possible to
use residual change scores as the residuals in the
regressions were skewed. Change scores from pre- to
post-intervention (on days 1, 2 and 3) were calculated
for the six brief ratings (i.e. shortness of breath, anxi-
ety, depression, stress, happiness and awareness), and
Mann-Whitney tests were used to compare the change
scores between the two groups. The changes in HADS
and PHLMS scores from pre-intervention on day 1 to
post-intervention on day 3 were computed, and Mann-
Whitney tests were used to compare the changes
between the two groups. w2 Tests were used to compare
the ratings for ‘usefulness of the intervention’ and
‘recommending the intervention to others’ between the
two groups. As we formulated specific hypotheses with
regard to the effect of the interventions, we retained a
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significance level of p < 0.05 throughout the analysis.
All data were analysed using Stata 12.
Ethical approval
All procedures performed in studies involving human
participants were in accordance with the ethical stan-
dards of the institutional and/or national research
committee and with the 1964 Helsinki declaration and
its later amendments or comparable ethical standards.
Results
The recruitment process is shown in Figure 1. A total
of 227 eligible patients were referred to the study by
clinicians. Of these, 77 (34%) had already been dis-
charged before they could be invited to participate, 42
Assessed for eligibility by 
physician and referred to 
research team (n=227)
Excluded  (n=147)
Discharged prior to invitaon (n=77)
Declined to parcipate (n=42)
Other reasons (n=26  )
Died soon aer admission (n=2)
Analysed  (n=24)
Paents completed data collecon (n = 24)
Lost to follow-up  (n=16)
Became too unwell to connue/withdrew (n = 1)
Unable to contact (n = 5)
Quesonnaires lost (n = 6)
Quesonnaire returned incomplete (n = 4)
Allocated to control (n=40)
Received allocated intervenon (n=40)
Paents completed data collecon (n = 26)
Lost to follow-up (n=14)
Became too unwell to connue/withdrew (n = 3)
Unable to contact (n = 1)
Quesonnaires lost in transit (n = 3)
Quesonnaire returned (n = 7)
Allocated to intervenon (n=40)
Received allocated intervenon (n=40)
Analysed  (n=26)
Randomized (n=80)
Recruitment
Allocaon
Follow up
Allocaon
Figure 1. CONSORT diagram: Recruitment process and number of participants enrolled in study and included in
analyses.
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(19%) were not interested, 26 (11%) did not meet the
inclusion criteria due to language or hearing prob-
lems, 2 patients (1%) died soon after admission and
80 (35%) were successfully recruited and rando-
mized. Thirty participants failed to listen to the audio
guide on days 2 and 3 and did not complete the post-
intervention questionnaires. Of these, 4 become more
unwell and withdrew, 6 were uncontactable, 9 ques-
tionnaires were lost by patients or in the post and 11
were returned incomplete. Analyses were therefore
based on a subsample of 50 participants (62.5% of
those recruited, n ¼ 24 body scan, n ¼ 26 control)
which had similar baseline characteristics to the total
sample. Table 1 presents the baseline characteristics
of the two groups for the total sample. Around two-
third declared no previous experience of mindfulness
techniques, and PHLMS scores were comparable to
those reported for the original validation of the
scale.31 According to the HADS, a quarter or less of
patients were classed as having high levels of
depression and anxiety at baseline. All baseline char-
acteristics, including pre-intervention scores for the
HADS, PHLMS and BORG dyspnoea scale, were
similar for the two groups in the total sample, as well
as in the subsample with data on both assessment
occasions.
Tables 2 and 3 present the mean scores for the brief
ratings pre- and post-intervention. There were no sig-
nificant group differences in the change scores for any
of these brief ratings, on any of the 3 days of measure-
ment, norwere there significant group differences in the
change scores for the HADS and PHLMS between pre-
intervention on day 1 and post-intervention on day 3.
Further analyses of the acceptability of the interven-
tions were conducted on a smaller group of 38 partici-
pants, for which these data were available. Sixty-five
per cent of the control group and 83% of the body scan
group reported that they found the intervention moder-
ately or very useful for helping them to relax. Addition-
ally, 50% of the control group and 83% of the body scan
Table 1. Baseline characteristics of participants in the treatment and control groups.
Categorical variable Body scan (N ¼ 40), n (%) Control (N ¼ 40), n (%)
Female 20 (50.0) 19 (47.5)
Professional/managerial 10 (25.0) 11 (27.5)
Retired/cannot work 37 (92.5) 35 (87.5)
Caucasian 38 (95.0) 38 (95.0)
Married/living with partner 21 (52.5) 18 (45.0)
Medication used for symptomatic relief/prevention of COPD 40 (100) 40 (100)
Domiciliary oxygen therapy used 12 (30.0) 9 (22.5)
Use of recreational drugs 4 (10.0) 2 (5.0)
Smokers 10 (25.0) 11 (27.5)
Nicotine replacement therapy used 0 (0.0) 5 (12.5)
HADS anxiety
Borderline (scores 8–10) 6 (15.0) 8 (20.0)
Moderate to severe (scores 11–24) 10 (25.0) 10 (25.0)
HADS depression
Borderline (scores 8–10) 10 (25.0) 8 (20.0)
Moderate to severe (scores 11–24) 6 (15.0) 7 (17.5)
Continuous variables Mean (SD) Mean (SD)
Age 70.0 (10.3) 72.6 (9.8)
Years of full-time education 11.1 (2.4) 11.0 (2.6)
The BORG dyspnoea scale (0 to 10) 4.4 (2.7) 3.8 (2.3)
Abbreviated mental state score (scores 0–10) 9.8 (0.5) 9.7 (0.6)
Number of cigarettes per day (current smokers only) 17.0 (19.1) 14.2 (5.8)
HADS anxiety score (0–21) 7.3 (4.7) 7.7 (4.3)
HADS depression score (0–21) 6.5 (3.3) 7.0 (3.2)
PHLMS awareness score (10–50) 36.7 (6.0) 37.8 (5.4)
PHLMS acceptance score (10–50) 30.2 (7.4) 30.1 (7.3)
COPD: chronic obstructive pulmonary disease; HADS: Hospital Anxiety and Depression Scale; PHLMS: Philadelphia Mindfulness Scale;
SD: standard deviation.
6 Chronic Respiratory Disease 0(0)
group stated that they would probably or definitely rec-
ommend the strategy to otherswho are trying tomanage
their anxiety and depression during COPD. The group
difference for usefulness did not achieve statistical sig-
nificance, but the finding for recommending the inter-
vention was significant (w ¼ 0.03 and p ¼ 0.03).
Discussion
Summary of the main findings
Our main findings showed that although there was a
tendency for there to be a change in most outcomes
for the mindfulness intervention versus control, there
were no significant effects of the intervention on any
day. There are several possible interpretations of the
lack of effect. First, based on previous literature
describing the high prevalence of anxiety and depres-
sion among patients with respiratory conditions,34–38
we expected to find that the majority of the patients in
this study, who had been admitted to an acute hospital
ward following an exacerbation of their COPD and
severe dyspnoea, would report high levels of anxiety
and depression at baseline. However, no more than
25% reported moderate to severe levels of HADS
anxiety or depression. Similarly, baseline scores for
the brief inventory items of dyspnoea, anxiety,
depression and stress were low. Therefore, there was
a potential floor effect, limiting the chances of finding
an effect of the intervention. These low scores among
inpatients are comparable to those in similar studies,
investigating psychological factors among COPD out-
patients,37,30,39 and we expected to observe compara-
tively higher levels of distress in inpatients recently
admitted for acute exacerbation of COPD. No previ-
ous data were available assessing these measures
among acute admissions. These low scores may
reflect the reassurance, relief and intensive support
patients had already experienced by receiving medi-
cal treatment prior to their baseline assessment for the
study. Their initial acute feelings of panic and anxiety
due to the exacerbation may have already passed by
the time they were recruited onto the study. As with
all studies of this type, there is also the possibility that
patients with higher levels of anxiety and depression
chose not to participate. We had anticipated that the
intervention may be useful in the inpatient context, but
Table 2. Brief inventory scores before and after listening to the recording on days 1, 2 and 3 for the treatment and
control groups.a
Brief inventory items
Day 1 (N ¼ 50) Day 2 (N ¼ 50) Day 3 (N ¼ 50)
Treatment
(n ¼ 24)
Control
(n ¼ 26)
Treatment
(n ¼ 24)
Control
(n ¼ 26)
Treatment
(n ¼ 24)
Control
(n ¼ 26)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
How short of breath do you feel right now?
Before 4.3 (1.6) 3.9 (2.6) 4.0 (1.8) 2.8 (1.5) 3.7 (2.0) 3.0 (2.2)
After 3.1 (2.0) 3.2 (2.4) 2.9 (1.5) 2.7 (2.1) 2.5 (1.7) 2.3 (2.5)
How anxious do you feel right now?
Before 3.3 (1.9) 3.2 (2.1) 3.0 (1.5) 3.0 (1.5) 3.0 (1.7) 2.4 (1.2)
After 2.4 (1.6) 2.8 (2.1) 2.7 (1.4) 2.8 (2.0) 2.2 (1.2) 2.2 (1.5)
How depressed do you feel right now?
Before 2.6 (1.9) 2.1 (1.4) 2.4 (1.8) 2.2 (1.2) 2.2 (1.6) 2.3 (1.4)
After 2.1 (1.8) 1.9 (1.5) 2.1 (1.5) 2.0 (1.4) 1.9 (1.4) 2.0 (1.3)
How stressed do you feel right now?
Before 2.2 (1.3) 2.6 (1.8) 2.6 (1.6) 2.6 (1.6) 2.1 (1.4) 2.7 (1.6)
After 2.0 (1.1) 2.4 (2.0) 2.3 (1.3) 2.5 (1.8) 2.0 (1.1) 2.2 (1.2)
How happy do you feel right now?
Before 4.7 (1.4) 4.3 (1.7) 4.0 (1.6) 3.7 (1.6) 4.2 (1.7) 3.5 (1.9)
After 4.9 (1.5) 4.3 (1.7) 4.6 (2.1) 3.9 (1.8) 4.8 (1.8) 4.1 (1.9)
I am aware of what thoughts are passing
through my mind
Before 4.3 (1.3) 4.3 (1.0) 4.3 (1.2) 3.8 (1.3) 4.2 (1.2) 3.7 (1.3)
After 4.3 (1.2) 4.0 (1.5) 4.3 (1.2) 4.0 (1.2) 4.3 (1.2) 3.7 (1.3)
SD: standard deviation.
aNo significant group differences at p < 0.05.
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the findings suggest that the patients may be insuffi-
ciently stressed to warrant such an intervention. It
would be useful to test the intervention in the patient’s
own environment, specifically at times when they are
experiencing acute shortness of breath and panic which
is common during acute exacerbations of COPD. In
this context, patients may need more guidance about
why, where and when to use the intervention.
The chances of finding a significant effect were
also limited by the control condition showing some
beneficial effects. This is consistent with the patients
anecdotally reporting that they liked the control inter-
vention. Around two-third reported that they found
the control intervention useful and half said they
would recommend it to others. Future studies may
need to consider using more passive and less engaging
control conditions. Additionally, it is worth consider-
ing whether the brief measures devised for this study
are sufficiently sensitive to the effects of the interven-
tion and these measures may require further testing
for reliability and validity.
Strengths and limitations of this study
It is the first study of a very brief 10-minute
mindfulness-based intervention for patients with
COPD and all participants had a diagnosis of COPD
confirmed by clinicians. The intervention was tested
on several occasions over 3 days; however, it would
be interesting to extend the duration of the data col-
lection period. The sample size achieved was ade-
quate for this type of study and similar to other
studies, such as those examining groups of patients
with chronic pain or smoking cessation groups.26–28
The study has some limitations. The study
achieved only a moderate follow-up rate over the
3-day period. There were no differences, however,
in the characteristics of the total sample recruited and
the subsample used in the analyses so it is unlikely
that this biased the results. The study was not blinded
so it is possible that this may have introduced some
potential bias. Participants were informed of the ratio-
nale for the study in that it sought to examine whether
the intervention effected mood and/or dyspnoea in
order to enable them to provide informed consent, but
this had no effect so it is unlikely that this caused bias
or pre-empted their responses.
On days 2 and 3, some patients were still in hospital
while some had already been discharged home and this
may have influenced the findings but the sample was
too small to test this statistically. Recruitment in the
context of an acute hospital setting was very challen-
ging. All patients had been admitted to an acute respira-
tory ward with an acute exacerbation of COPD. The
average duration of stay on the acute ward for stabiliza-
tion was 3 days before being transferred to a non-acute
setting within the hospital, to another hospital or home.
It was therefore important to recruit patients when they
were well enough but before they were transferred.
Data were collected by part-time researchers. The
patient turnover was very high and the timescale for
recruitment was very short. These factors help to
explain why only 35% of patients identified by the
clinician as eligiblewere actually recruited. In addition,
some patients while medically stable were simply very
tired in the aftermath of the medical event or treatment
and unwilling to participate. While the clinician
screened patients for medical exclusion criteria, this
did not include other study inclusion criteria such as
English language and hearing problems which
accounted for 11% of exclusions. This may reduce
generalizability of the results, but these problems
would be difficult to overcome within this population
group, nevertheless this study provides some insight
into the acceptability and potential effectiveness of
this brief intervention. This study is therefore specific
to acute hospital inpatients, and the results may be
different for other COPD populations who are
community-based or whose COPD is more stable.
Table 3. Scores for the HADS and PHLMS for the treat-
ment and control groups on days 1 and 3.a
HADS and PHLMS scores
Treatment
(n ¼ 24)
Control
(n ¼ 26)
Mean (SD) Mean (SD)
HADS anxiety score (0–21)
Day 1 7.3 (4.9) 7.4 (4.5)
Day 3 7.5 (5.2) 8.4 (4.5)
HADS depression score (0–21)
Day 1 6.0 (2.9) 7.2 (2.8)
Day 3 6.3 (3.6) 7.4 (4.1)
HADS total score (0–42)
Day 1 13.3 (6.9) 14.6 (6.3)
Day 3 13.9 (7.9) 15.8 (8.1)
PHLMS awareness score (10–50)
Day 1 37.5 (5.4) 37.2 (5.9)
Day 3 37.5 (5.4) 36.2 (7.1)
PHLMS acceptance score (10–50)
Day 1 30.1 (7.2) 30.1 (8.5)
Day 3 28.8 (8.1) 28.3 (9.4)
PHLMS: Philadelphia Mindfulness Scale; HADS: Hospital Anxiety
and Depression Scale; SD: standard deviation.
aNo significant group differences at p < 0.05.
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Finally, this study relied wholly on quantitative data
and, in order to interpret the negative findings, it would
have been useful to have qualitative data relating to the
patients’ experience of using the intervention. These
data would also aid in identifying reasons why some
patients failed to return their questionnaires.
Relation to previous literature and implications
for future practice
These null findings are inconsistent with previous
studies investigating the immediate effects of
mindfulness-based interventions on psychological
variables which have found benefit for patients with
chronic pain and for smokers.26–28 It is possible that
this intervention is effective for these populations but
not for acute patients suffering with COPD. This older
population may be less receptive to the benefits of the
intervention or to the medium through which it was
delivered, for example, anecdotally the patients
expressed some challenges in being sufficiently dex-
trous to use the MP3 players. Also, they raised issues
about the volume of the audios being too low to hear
comfortably. This was a student study and was not
externally funded, so access to greater funding and
more advanced technology may resolve these issues.
It is encouraging that participants provided high ratings
for ‘usefulness’ and ‘recommending the intervention’
which suggest that the intervention was well received.
The intervention may also be more effective if com-
bined with other brief interventions such as a brief
mindfulness training session. Further studies may need
to consider adapting the technology to the needs of an
elderly population, including other technologies such
as phone apps and downloads. Patients generally liked
the intervention and derived some benefit from it. We
hope that findings from our study will help to inform
future researchers in the development of brief interven-
tions for COPD patients aimed at relieving anxious and
depressive feelings and dyspnoea.
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